John Simon Craw insider trades: International Stem Cell stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 10, 2014 | ISCO:OB | ↑ Buy | 10,000 | $0.10 | $1K | Direct | Oct 10, 2014 (0d) |
| Sep 26, 2014 | ISCO.OB | ↑ Buy | 10,000 | $0.10 | $1K | Direct | Sep 26, 2014 (0d) |
| Sep 12, 2014 | ISCO.OB | ↑ Buy | 10,000 | $0.10 | $1K | Direct | Sep 12, 2014 (0d) |
| Aug 29, 2014 | ISCO.OB | ↑ Buy | 10,000 | $0.10 | $1K | Direct | Sep 2, 2014 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John Simon Craw's insider trades
John Simon Craw is Executive Vice President at International Stem Cell. Since Aug 29, 2014, John has reported 4 open-market purchases worth $4K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.